Landscapes / Companies
Shanghai Ark Biopharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
1 in Phase 1
Drugs
3
in active trials · 5 in all
Trials
3 active
17 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Sep 2028Phase 3 trial completes | |||
| Next date | 30 Sep 2028 · Phase 3 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Open drug page | |||||
— |
Phase 2/3 | Dec 2028Phase 2/3 trial completes | |||
| Next date | Dec 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Respiratory Syncytial Virus Infections | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2027Phase 1 trial completes | |||
| Next date | Apr 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021